Inarticulate ramblings of a management consultant

the day to day experiences of a consultant operating in weird and wonderful client situations

Deals that don’t complete – the consequences of being left at the ‘altar’

What happens when the deal you’ve been banking on is pulled  “Investors should worry whenever bosses and bankers succumb to deal-fever, since so many corporate transactions end up destroying value. The latest crop has some of the tell-tale signs of danger: high ego, high price and over-confidence.” You’re probably not surprised to hear that this is a quote from the FT…as relevant today as it was when it was written, […]

Continue Reading →

The rise of China’s serial acquirers – M&A China style appears to be a ‘non-contact’ sport!

According to Dealogic, 102 outbound Chinese transactions have been announced to date worth USD 81.6 billion up from USD 11.2 billion for the same period last year… Some of them have been truly momentous:  Haier’s intention to acquire the GE Appliance business, a business which is steeped in American corporate history. ChemChina’s bid for Syngenta, the sheer size of which is eye popping at USD 48 billion. HNA Group’s bid for […]

Continue Reading →

Sponsorship – comes in many shapes and sizes

A few years ago when I was contemplating the opportunity to come to Asia and going through a rather tortuous International Mobility exercise (which seemed full of process but lacked any sense of progress), a colleague whispered to me the secret of all such moves….’sponsorship’. Find a sponsor, he said, one who has money and influence, and all the obstacles you’re currently facing through the ‘official’ processes will magically disappear! […]

Continue Reading →

Where does effective post acquisition integration start? In the boardroom or on the office floor…

One of my reading obsessions for the last couple of years has been the subject of behavioural economics. A key finding (from the psychology arm of the science) is the concept of ‘unconscious bias’;  the idea that despite the contention from a rational perspective that we are not biased, the evidence suggests that we are influenced by colour and race in our decisions and inclinations. There’s a good short video on […]

Continue Reading →

Revenue synergies – the last great hope in the justification of paying too much for too little

The announcement this morning of the acquisition of Baxalta by Shire suggests that the wave of pharmaceutical acquisitions is still ongoing. The current market fluctuation may help others to continue their quest in what is probably the largest sector consolidation we’ve seen in a decade or two. The Shire share price reaction is also interesting…a fall of 8% suggests that investors are increasingly concerned that for this specific deal, and […]

Continue Reading →

2015 and all that

It’s rare to have a ringside view of events on the global stage where the effect on one’s own part of the world is relatively limited. 2015 has been the year of mergers and acquisitions with whole sectors (pharmaceuticals, cement, beer, oil and gas) going through such a radical overhaul that they have indeed truly changed. In the majority of cases, the case for consolidation has largely been driven by […]

Continue Reading →